These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 2685857
21. Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease? Tabakman R, Lecht S, Lazarovici P. Bioessays; 2004 Jan; 26(1):80-90. PubMed ID: 14696044 [Abstract] [Full Text] [Related]
23. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease. Guay DR. Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539 [Abstract] [Full Text] [Related]
24. Selegiline and the prophylaxis of Parkinson's disease. Sandler M, Willoughby J, Glover V, Gibb C. J Neural Transm Suppl; 1987 Dec; 25():35-43. PubMed ID: 3123604 [Abstract] [Full Text] [Related]
25. Role of MAO A and B in neurotransmitter metabolism and behavior. Shih JC, Chen K, Ridd MJ. Pol J Pharmacol; 1999 Dec; 51(1):25-9. PubMed ID: 10389141 [Abstract] [Full Text] [Related]
26. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B]. Knoll J. Vopr Med Khim; 1997 Dec; 43(6):482-93. PubMed ID: 9503565 [Abstract] [Full Text] [Related]
27. Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease. Youdim MB. J Neural Transm Suppl; 1986 Dec; 22():91-105. PubMed ID: 3097263 [Abstract] [Full Text] [Related]
28. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Hotamisligil GS, Girmen AS, Fink JS, Tivol E, Shalish C, Trofatter J, Baenziger J, Diamond S, Markham C, Sullivan J. Mov Disord; 1994 May; 9(3):305-10. PubMed ID: 7913737 [Abstract] [Full Text] [Related]
35. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Levitt P, Pintar JE, Breakefield XO. Proc Natl Acad Sci U S A; 1982 Oct; 79(20):6385-9. PubMed ID: 6755469 [Abstract] [Full Text] [Related]
36. Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem. Westlund KN, Denney RM, Rose RM, Abell CW. Neuroscience; 1988 May; 25(2):439-56. PubMed ID: 3399053 [Abstract] [Full Text] [Related]
37. Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry. Saura J, Bleuel Z, Ulrich J, Mendelowitsch A, Chen K, Shih JC, Malherbe P, Da Prada M, Richards JG. Neuroscience; 1996 Feb; 70(3):755-74. PubMed ID: 9045087 [Abstract] [Full Text] [Related]
39. Localization of monoamine oxidases A and B in primate brains relative to neuron-specific and non-neuronal enolases. Campbell IC, Marangos PJ, Parma A, Garrick NA, Murphy DL. Neurochem Res; 1982 Jun; 7(6):657-66. PubMed ID: 7121716 [Abstract] [Full Text] [Related]
40. Perspectives on MAO-B in aging and neurological disease: where do we go from here? Kumar MJ, Andersen JK. Mol Neurobiol; 2004 Aug; 30(1):77-89. PubMed ID: 15247489 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]